SICHUAN HZ-YEG MEDICAL Co Ltd

SICHUAN HZ-YEG MEDICAL Co Ltd has a market capitalization of 2.43 billion CNY and an enterprise value to revenue ratio of 0.62, indicating a relatively low valuation compared to revenue. The company's liquidity position is assessed as medium, with a debt-to-equity ratio of 0.41, suggesting a moderate level of leverage. However, the company reported negative operating cash flow of -13.23 million CNY and capital expenditure of -7.57 million CNY, which may signal potential liquidity constraints. In terms of profitability, the company's financials show a total equity of 820.81 million CNY and total liabilities of 946.16 million CNY, resulting in a net cash position that is negative after subtracting total debt. This suggests that the company may be facing challenges in maintaining a strong balance sheet. The company's revenue of 4.45 billion CNY indicates a significant scale of operations, but the profitability metrics are not provided in the current dataset. The company's revenue is primarily concentrated in the Chinese market, as disclosed in its business segments. There is no detailed breakdown of geographic exposure or segment performance in the provided data, which limits the ability to assess the diversification of its revenue streams. The company's growth trajectory is not explicitly detailed in the provided data, but the current financial snapshot does not indicate a strong growth momentum. The company's capital expenditure of -7.57 million CNY suggests a reduction in investment in physical assets, which could be a sign of cost-cutting or a strategic shift. The risk assessment for the company highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt indicates potential liquidity constraints. The company's dilution risk is assessed as low, suggesting that there is little immediate threat of share dilution affecting shareholder value. Recent events and filings have not been detailed in the provided data, so there is no specific information on recent corporate actions or strategic developments. The company's financial performance and risk profile suggest that it may be in a period of financial adjustment or restructuring.